Caricamento...

First-line oral antiviral therapies showed similar efficacies in suppression of serum HBcrAg in chronic hepatitis B patients

BACKGROUND: Serum hepatitis B core-related antigen (HBcrAg) is a potential surrogate marker for intra-hepatic covalently-closed circular DNA in chronic hepatitis B (CHB). We aimed to study the profiles of serum HBcrAg in CHB patients treated with first-line nucleos(t)ide analogues (NA): entecavir (E...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Gastroenterol
Autori principali: Mak, Lung-Yi, Wong, Danny Ka-Ho, Cheung, Ka-Shing, Seto, Wai-Kay, Fung, James, Yuen, Man-Fung
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2021
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7968194/
https://ncbi.nlm.nih.gov/pubmed/33731023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-021-01711-x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !